Akebia Therapeutics Inc (NASDAQ:AKBA)

10.20
Delayed Data
As of Mar 04
 +0.72 / +7.59%
Today’s Change
8.47
Today|||52-Week Range
31.00
-12.37%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close9.48
Today’s open9.48
Day’s range-- - --
Volume138,679
Average volume (3 months)135,292
Market cap$192.8M
Dividend yield--
Data as of 03/04/2015

Growth & Valuation

Earnings growth (last year)-107.97%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
AKAOAchaogen Inc-0.33-3.07%
MEIPMEI Pharma Inc-0.24-4.18%
MDGNMedgenics Inc+0.26+3.27%
FOMXFoamix Pharmaceutica...-0.05-0.55%
Data as of 03/04/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$69.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John P. Butler
CFO, Treasurer, SVP &
Head-Investor Relations
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account